Anti-SLC25A18 monoclonal antibody

Pre-made anti-SLC25A18 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SLC25A18/SLC25A18 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1668-Ab-1/ GM-Tg-hg-IP1668-Ab-2Anti-Human SLC25A18 monoclonal antibodyHuman
GM-Tg-rg-IP1668-Ab-1/ GM-Tg-rg-IP1668-Ab-2Anti-Rat SLC25A18 monoclonal antibodyRat
GM-Tg-mg-IP1668-Ab-1/ GM-Tg-mg-IP1668-Ab-2Anti-Mouse SLC25A18 monoclonal antibodyMouse
GM-Tg-cynog-IP1668-Ab-1/ GM-Tg-cynog-IP1668-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC25A18 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1668-Ab-1/ GM-Tg-felg-IP1668-Ab-2Anti-Feline SLC25A18 monoclonal antibodyFeline
GM-Tg-cang-IP1668-Ab-1/ GM-Tg-cang-IP1668-Ab-2Anti-Canine SLC25A18 monoclonal antibodyCanine
GM-Tg-bovg-IP1668-Ab-1/ GM-Tg-bovg-IP1668-Ab-2Anti-Bovine SLC25A18 monoclonal antibodyBovine
GM-Tg-equg-IP1668-Ab-1/ GM-Tg-equg-IP1668-Ab-2Anti-Equine SLC25A18 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1668-Ab-1/ GM-Tg-hg-IP1668-Ab-2; GM-Tg-rg-IP1668-Ab-1/ GM-Tg-rg-IP1668-Ab-2;
GM-Tg-mg-IP1668-Ab-1/ GM-Tg-mg-IP1668-Ab-2; GM-Tg-cynog-IP1668-Ab-1/ GM-Tg-cynog-IP1668-Ab-2;
GM-Tg-felg-IP1668-Ab-1/ GM-Tg-felg-IP1668-Ab-2; GM-Tg-cang-IP1668-Ab-1/ GM-Tg-cang-IP1668-Ab-2;
GM-Tg-bovg-IP1668-Ab-1/ GM-Tg-bovg-IP1668-Ab-2; GM-Tg-equg-IP1668-Ab-1/ GM-Tg-equg-IP1668-Ab-2
Products NameAnti-SLC25A18 monoclonal antibody
Formatmab
Target NameSLC25A18
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SLC25A18 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1668-Ag-1Recombinant multi-species GHC2/ SLC25A18/ GC2 protein


    Target information

    Target IDGM-IP1668
    Target NameSLC25A18
    Gene ID83733,71803,681896,718491,100856697,101082416,100055121
    Gene Symbol and Synonyms1500015I14Rik,GC2,SLC25A18
    Uniprot AccessionQ9H1K4,Q505J6
    Uniprot Entry NameGHC2_HUMAN,GHC2_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000182902
    Target ClassificationN/A

    The target: SLC25A18, gene name: SLC25A18, also named as GC2. Predicted to enable L-aspartate transmembrane transporter activity and L-glutamate transmembrane transporter activity. Predicted to be involved in L-glutamate transmembrane transport; aspartate transmembrane transport; and malate-aspartate shuttle. Predicted to be located in mitochondrial inner membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.